Sumitomo Mitsui Trust Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-759,129
Closed -$50M 1148
2023
Q3
$50M Sell
759,129
-142,455
-16% -$10.7M 0.04% 455
2023
Q2
$73.4M Buy
901,584
+155,058
+21% +$11M 0.06% 364
2023
Q1
$44.4M Buy
746,526
+71,113
+11% +$3.95M 0.03% 535
2022
Q4
$33M Buy
675,413
+13,415
+2% +$620K 0.03% 606
2022
Q3
$34.1M Buy
+661,998
New +$39.3M 0.03% 584

Other funds holding THC

Sumitomo Mitsui Trust Group's THC Position: Q4 2023 in Review

Sumitomo Mitsui Trust Group sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 759,129 shares — an estimated $50M sold.

Sumitomo Mitsui Trust Group first reported a position in THC in Q3 2022 and held it in 5 quarters. The position peaked at $73.4M in Q2 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Sumitomo Mitsui Trust Group reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 759,129 Tenet Healthcare shares in Q4 2023, an estimated $50M.
  • Sumitomo Mitsui Trust Group first reported a position in Tenet Healthcare in Q3 2022 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Tenet Healthcare position peaked at $73.4M in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2023, filed 30 Jan 2024.